Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
1114.64
↑ 213% above average
Average (8y)
355.97
Historical baseline
Range
High:1114.64
Low:65.03
CAGR
+33.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 1114.64 | +12.0% |
| 2023 | 994.97 | +120.7% |
| 2022 | 450.85 | +93.5% |
| 2021 | 232.97 | +258.3% |
| 2020 | 65.03 | -21.6% |
| 2019 | 82.93 | +11.4% |
| 2018 | 74.48 | -0.3% |
| 2017 | 74.71 | -34.0% |
| 2016 | 113.11 | - |